Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.48 USD | -0.55% |
|
-2.18% | +9.52% |
11:51am | Berenberg Adjusts Price Target on Corteva to $56 From $54, Maintains Hold Rating | MT |
Jun. 25 | RBC Capital Adjusts Price Target on Corteva to $62 From $64 | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With a 2024 P/E ratio at 26.41 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.52% | 36.58B | C | ||
-.--% | 11.65B | - | B+ | |
+26.24% | 7.85B | - | C- | |
-11.72% | 6.95B | A | ||
+7.90% | 6.88B | B- | ||
-11.17% | 5.58B | B+ | ||
-10.02% | 5.4B | B | ||
-2.57% | 5.13B | C+ | ||
+25.96% | 4.96B | B- | ||
+5.71% | 3.95B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CTVA Stock
- Ratings Corteva, Inc.